BMY Price / Book | BRISTOL-MYERS SQUIBB COMPANY

BRISTOL-MYERS SQUIBB COMPANY (BMY) Price / Book

2026-09-03: Price/Book Ratio 6.23.
2026-06-30: Price/Book Ratio 5.27.
2026-03-31: Price/Book Ratio 6.15.
2025-12-31: Price/Book Ratio 5.94.

Historical market capitalization divided by filed shareholder equity.

Available history: 2009-06-30 to 2026-09-03
Data captured: 2026-09-04

Historical Price/Book Ratio

Date	Price/Book Ratio
2026-09-03	6.23
2026-06-30	5.27
2026-03-31	6.15
2025-12-31	5.94
2025-09-30	4.95
2025-06-30	5.4
2025-03-31	7.12
2024-12-31	7.02
2024-09-30	6.12
2024-06-30	4.95
2024-03-31	6.65
2023-12-31	3.55
2023-09-30	4.18
2023-06-30	4.2
2023-03-31	4.57
2022-12-31	4.93
2022-09-30	4.65
2022-06-30	5.03
2022-03-31	4.92
2021-12-31	3.85
2021-09-30	3.53
2021-06-30	4.03
2021-03-31	3.75
2020-12-31	3.71
2020-09-30	2.72
2020-06-30	2.7
2020-03-31	2.53
2019-12-31	2.03
2019-09-30	4.68
2019-06-30	4.62
2019-03-31	5.13
2018-12-31	6.05
2018-09-30	7.43
2018-06-30	7.33
2018-03-31	8.08
2017-12-31	8.54
2017-09-30	7.06
2017-06-30	6.22
2017-03-31	6.21
2016-12-31	6.04
2016-09-30	5.77
2016-06-30	8.24
2016-03-31	7.41
2015-12-31	8.04
2015-09-30	6.55
2015-06-30	7.34
2015-03-31	6.92
2014-12-31	6.59
2014-09-30	5.61
2014-06-30	5.25
2014-03-31	5.56
2013-12-31	5.77
2013-09-30	5.17
2013-06-30	5.12
2013-03-31	4.95
2012-12-31	3.95
2012-09-30	4.01
2012-06-30	3.75
2012-03-31	3.49
2011-12-31	3.74
2011-09-30	3.21
2011-06-30	3.02
2011-03-31	2.82
2010-12-31	2.88
2010-09-30	2.91
2010-06-30	2.73
2010-03-31	3.01
2009-12-31	3.37
2009-09-30	3.07
2009-06-30	2.85

Similar stocks

Stock Name	Country	Market Cap	PE Ratio
VERTEX PHARMACEUTICALS INC / MA (VRTX)	United States	$132.481B	28.56
PFIZER INC (PFE)	United States	$162.042B	31.94
ABBOTT LABORATORIES (ABT)	United States	$176.045B	28.47
REGENERON PHARMACEUTICALS, INC. (REGN)	United States	$74.751B	21.53
ALNYLAM PHARMACEUTICALS, INC. (ALNY)	United States	$33.420B	54.94
Zoetis Inc. (ZTS)	United States	$29.045B	11.38
INSMED Inc (INSM)	United States	$26.566B	-26.60
Roivant Sciences Ltd. (ROIV)		$26.105B	-96.08
Royalty Pharma plc (RPRX)	United States	$22.628B
UNITED THERAPEUTICS Corp (UTHR)	United States	$20.249B	17.64